The serum TNF-α and IL-6 levels in the NAFLD group decreased after drug intervention [37], while in the GXZY-NASH and GXZY-fibrosis groups, SOD levels increased, MDA expression decreased, and the oxidative stress response was inhibited. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.